Plant ID: NPO5664
Plant Latin Name: Davallia mariesii
Taxonomy Genus: Davallia
Taxonomy Family: Davalliaceae
NCBI TaxonomyDB:
29639
Plant-of-the-World-Online:
n.a.
China
TDP1; ALPL; RECQL; P4HB; HSD17B10; HPGD; ALDH1A1; AKR1B1; | |
GAA; | |
FYN; EGFR; | |
CA2; CA6; CA1; | |
NFKB1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | P4HB | Protein disulfide-isomerase | P07237 | CHEMBL5422 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Protein Kinase | FYN | Tyrosine-protein kinase FYN | P06241 | CHEMBL1841 |
Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0009725; response to hormone | 2.669E-07 | 2.906E-03 | AKR1B1, ALPL, CA2, EGFR, FYN, HPGD, NFKB1 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.714E-07 | 2.906E-03 | CA1, CA2, CA6 |
MF | GO:0003824; catalytic activity | GO:0003824; catalytic activity | 6.983E-07 | 5.069E-03 | AKR1B1, ALDH1A1, ALPL, CA1, CA2, CA6, EGFR, FYN, GAA, HPGD, HSD17B10, P4HB, RECQL, TDP1 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.664E-06 | 1.160E-02 | CA1, CA2, CA6 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.923E-06 | 1.531E-02 | CA1, CA2, CA6 |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 9.629E-06 | 1.760E-02 | AKR1B1, ALPL, FYN, HPGD, NFKB1 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 8.428E-06 | 1.760E-02 | CA1, CA2 |
CC | GO:0043226; organelle | GO:0031982; vesicle | 9.256E-06 | 1.760E-02 | AKR1B1, ALDH1A1, ALPL, CA1, CA2, CA6, EGFR, FYN, GAA, HPGD, P4HB |
BP | GO:0008283; cell proliferation | GO:0048661; positive regulation of smooth muscle cell proliferation | 2.574E-05 | 4.004E-02 | AKR1B1, EGFR, HPGD |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.306E-07 | 2.329E-05 | CA1, CA2, CA6 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.256E-04 | 1.139E-02 | GAA, AKR1B1 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.095E-03 | 2.710E-02 | EGFR, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.162E-03 | 2.710E-02 | EGFR, NFKB1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.610E-03 | 2.710E-02 | GAA, ALDH1A1, AKR1B1, ALPL, HSD17B10 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 1.375E-03 | 2.710E-02 | FYN, EGFR |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.980E-03 | 2.857E-02 | EGFR, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 2.640E-03 | 3.019E-02 | EGFR, NFKB1 |
09150 Organismal Systems | 09151 Immune system | hsa04660 | T cell receptor signaling pathway | 2.691E-03 | 3.019E-02 | FYN, NFKB1 |
09150 Organismal Systems | 09158 Development | hsa04380 | Osteoclast differentiation | 4.291E-03 | 3.533E-02 | FYN, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colon cancer | C50 | ALPL; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities | Genetic disease | Q00-Q99 | ALPL; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |